Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit
Introduction: The event of SARS-CoV-2 serological assessments is very large. The exterior validation of their efficiency is required earlier than use in scientific routine follow.
Aims: Our examine goals at assessing the analytical and scientific efficiency of two ELISA assessments detecting antibodies directed in opposition to the virus nucleocapsid protein: The NovaLisa® SARS-CoV-2 IgG, IgA, and IgM check (NovaTec®) permitting a separate detection of every antibody and the Platelia® SARS-CoV-2 Complete Ab check (Bio-Rad®) detecting complete antibodies (IgM, IgA and IgG).
Strategies: 200 and eight COVID-19 samples from 48 RT-qPCR confirmed sufferers have been used to carry out the sensitivity evaluation. Non-SARS-CoV-2 sera (n = 79) with a possible cross-reaction to SARS-CoV-2 immunoassays have been included within the specificity evaluation. As well as, utilizing ROC curves, tailored cut-off for enchancment of the performances have been proposed. The kinetics of those antibodies was additionally assessed over Eight weeks.
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit
Outcomes: Two weeks after the RT-qPCR constructive detection, the NovaLisa® check reveals a sensitivity and specificity of 94.9% (95%CI: 83.1-98.6%) and 96.2% (95%CI: 89.4-98.7%) for IgG, of 89.7% (95%CI: 76.4-95.9%) and 98.7% (95%CI:93.2-98.8%) for IgA, and of 48.7% (95%CI: 33.9-63.8%) and 98.7% (95%CI:93.2-99.8%) for IgM. With the Platelia® system, the specificity and sensitivity have been 97.4% (95%CI: 92.1-99.7%) and 94.9% (95%CI:87.7-98.0%) for complete antibodies utilizing the tailored cut-offs.
Conclusion: The NovaLisa® and the Platelia® assessments have passable analytical performances. The scientific performances are wonderful for IgG, IgA and complete antibodies particularly if the cut-off is optimized. This text is protected by copyright. All rights reserved
Mouse LIF |
MBS692107-5x001mg |
MyBiosource |
5x0.01mg |
EUR 1080 |
LIF,Mouse |
E34M066M |
EnoGene |
5 μg |
EUR 155 |
LIF, Mouse |
MBS8575391-0005mg |
MyBiosource |
0.005mg |
EUR 245 |
LIF, Mouse |
MBS8575391-5x0005mg |
MyBiosource |
5x0.005mg |
EUR 940 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592457-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592457-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592457-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592458-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592458-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592458-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592459-01mg |
MyBiosource |
0.1mg |
EUR 365 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592459-05mg |
MyBiosource |
0.5mg |
EUR 530 |
Mouse Anti-Human LIF Monoclonal Antibody |
MBS592459-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2140 |
Mouse LIF Protein |
E40MOP1672 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
E40MOP2026 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
E40MOP2028 |
EnoGene |
20ug |
EUR 495 |
LIF, Mouse, Monoclonal Antibody, Mouse |
MBS555093-01mg |
MyBiosource |
0.1mg |
EUR 745 |
LIF, Mouse, Monoclonal Antibody, Mouse |
MBS555093-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3210 |
LIF siRNA (Mouse) |
MBS8224619-15nmol |
MyBiosource |
15nmol |
EUR 405 |
LIF siRNA (Mouse) |
MBS8224619-30nmol |
MyBiosource |
30nmol |
EUR 565 |
LIF siRNA (Mouse) |
MBS8224619-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
Recombinant Mouse LIF |
Z200195 |
ABM |
10 µg |
EUR 85 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200197 |
ABM |
100 µg |
EUR 385 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200199 |
ABM |
1.0 mg |
EUR 1200 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200485 |
ABM |
100 µg |
EUR 1500 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
MBS7609292-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Mouse LIF |
MBS7609292-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Mouse LIF |
MBS7609292-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Mouse LIF |
MBS7609292-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Mouse LIF |
MBS4159936-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Mouse LIF |
MBS4159936-01mg |
MyBiosource |
0.1mg |
EUR 560 |
Recombinant Mouse LIF |
MBS4159936-1mg |
MyBiosource |
1mg |
EUR 1500 |
Recombinant Mouse LIF |
MBS4159936-5x1mg |
MyBiosource |
5x1mg |
EUR 6500 |
Recombinant Mouse LIF |
P1174-.005 |
ApexBio |
5ug |
EUR 108.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF |
P1174-.1 |
ApexBio |
100ug |
EUR 840.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Mouse LIF |
P1174-.5 |
ApexBio |
500ug |
EUR 1885.6 |
Description: Peptides & Proteins|Recombinant Proteins |
Anti-Mouse LIF Antibody |
103-M263 |
ReliaTech |
100 µg |
EUR 399 |
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Anti-Mouse LIF Antibody |
103-PA05S |
ReliaTech |
100 µg |
EUR 126 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
LIF (mouse), (recombinant) |
MBS566073-1mL |
MyBiosource |
1mL |
EUR 1470 |
LIF (mouse), (recombinant) |
MBS566073-5x1mL |
MyBiosource |
5x1mL |
EUR 6555 |
Mouse LIF ELISA Kit |
E28L0650 |
EnoGene |
96T |
EUR 666.67 |
Mouse LIF ELISA Kit |
EK5250 |
SAB |
96 tests |
EUR 599 |
|
Mouse LIF ELISA Kit |
EML0014 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse LIF shRNA Plasmid |
20-abx971321 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
LIF, Human, Monoclonal Antibody, Mouse |
MBS555094-01mg |
MyBiosource |
0.1mg |
EUR 745 |
LIF, Human, Monoclonal Antibody, Mouse |
MBS555094-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3210 |
Recombinant Mouse LIF protein |
IMP-1308 |
Creative BioMart |
10µg |
EUR 360 |
|
Description: Recombinant Proteins |
Mouse LIF Recombinant Protein |
M30-007 |
ReliaTech |
10 µg |
EUR 99.75 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Mouse LIF Recombinant Protein |
M30-008 |
ReliaTech |
50 µg |
EUR 246.75 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Recombinant Mouse LIF Protein |
R01400-1 |
BosterBio |
100ug/vial |
EUR 352.8 |
Recombinant Mouse LIF protein |
CD00323-5ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
5ug |
EUR 176 |
|
Description: Leukemia inhibitory factor (LIF) is a member of Interleukin 6 family. This protein is mainly expressed in the trophectoderm of the developing embryo, with its receptor LIFR expressed throughout the inner cell mass. LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes. LIF is used in mouse embryonic stem cell culture, because that removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential or pluripotency. It is also used in phase II clinical trial, which can assist embryo implantation in women who have failed to become pregnant despite assisted reproductive technologies (ART). Mature mouse LIF shares 78 % a.a. sequence identity with Human LIF. |
Recombinant Mouse LIF Protein |
PKSM041100-100ug |
Elabscience Biotech |
100ug |
EUR 739 |
|
Description: Mouse |
Recombinant Mouse LIF Protein |
PKSM041100-20ug |
Elabscience Biotech |
20ug |
EUR 249 |
|
Description: Mouse |
Recombinant Mouse LIF Protein |
MBS8249390-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Mouse LIF Protein |
MBS8249390-005mg |
MyBiosource |
0.05mg |
EUR 480 |
Recombinant Mouse LIF Protein |
MBS8249390-05mg |
MyBiosource |
0.5mg |
EUR 2825 |
Recombinant Mouse LIF Protein |
MBS8249390-5x05mg |
MyBiosource |
5x0.5mg |
EUR 12640 |
Recombinant Mouse LIF Protein |
MBS1751002-01mg |
MyBiosource |
0.1mg |
EUR 315 |
Recombinant Mouse LIF Protein |
MBS1751002-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1270 |
A digital ELISA to quantitate COVID-19 antibodies in affected person serum
-
Enzyme-linked immunosorbent assays (ELISAs) are used extensively in biotechnology, pharmaceutical, and scientific drugs labs. On the identical time, they look like underrepresented in chemistry and biochemistry curricula, although their sensitivity, selectivity, and ease of use would argue for his or her widespread use.
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit
Influenza A (A / Brisbane / 10 / 07) H3N2 Protein |
abx060621-50g |
Abbexa |
50 µg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07948 |
CHI Scientific |
10µg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07949 |
CHI Scientific |
50µg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
7-07950 |
CHI Scientific |
1mg |
Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
MBS143232-001mg |
MyBiosource |
0.01mg |
EUR 240 |
Influenza A Virus H3N2 Brisbane 10/07 |
MBS143232-005mg |
MyBiosource |
0.05mg |
EUR 310 |
Influenza A Virus H3N2 Brisbane 10/07 |
MBS143232-1mg |
MyBiosource |
1mg |
EUR 2375 |
Influenza A Virus H3N2 Brisbane 10/07 |
MBS143232-5x1mg |
MyBiosource |
5x1mg |
EUR 10370 |
H3N2 Influenza-A Virus Brisbane 10/07 |
rAP-5410 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
20-abx260509 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
abx260509-10g |
Abbexa |
10 µg |
EUR 325 |
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
abx260509-2g |
Abbexa |
2 µg |
EUR 225 |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen |
11-567 |
ProSci |
0.1 mg |
EUR 632.4 |
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2) |
Influenza A Strain A/Brisbane/10/07 (H3N2) Protein |
GWB-T00035 |
GenWay Biotech |
1mg |
Ask for price |
Influenza A (A/Brisbane/10/06) |
MBS318591-1mg |
MyBiosource |
1mg |
EUR 1895 |
Influenza A (A/Brisbane/10/06) |
MBS318591-5x1mg |
MyBiosource |
5x1mg |
EUR 8355 |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
IFLUABN1007H3N2ALR100UG |
Innovative research |
each |
EUR 738 |
|
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
MBS8431003-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
MBS8114355-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
MBS8114355-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8114357-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8114357-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza A, Brisbane 10/06 (H3N2) |
MBS655118-1mg |
MyBiosource |
1mg |
EUR 1690 |
Influenza A, Brisbane 10/06 (H3N2) |
MBS655118-5x1mg |
MyBiosource |
5x1mg |
EUR 7460 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
MBS8114356-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
MBS8114356-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza A H1N1 (A/Brisbane/02/2018) Neuraminidase/NA Insect Cell Lysate (WB positive control) |
MBS8119887-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Influenza A H1N1 (A/Brisbane/02/2018) Nucleoprotein/NP Insect Cell Lysate (WB positive control) |
MBS8119889-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8114342-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8114342-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza B (B/Brisbane/60/2008) Nucleoprotein/NP Insect Cell Lysate (WB positive control) |
MBS8119895-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
MBS8115772-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
MBS8115772-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8115774-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
MBS8115774-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
MBS8114341-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
MBS8114341-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza B (B/Brisbane/3/2007) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control) |
MBS8116043-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza B (B/Brisbane/3/2007) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control) |
MBS8116043-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
H3N2 Influenza A- Virus Brisbane 10/2007 Recombinant |
rAP-5428 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza A H3N2 (A/Brisbane/10/2007) HA protein, His Tag |
E40VAG023 |
EnoGene |
20ug |
EUR 495 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
MBS8115773-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
MBS8115773-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza A virus H3N2 (Brisbane) Antigen |
VAC-0271 |
Creative BioMart |
0.5ml |
EUR 1598.4 |
Description: Protein |
Influenza virus B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cells Cell Lysate (WB positive control) |
MBS8115775-03mg |
MyBiosource |
0.3mg |
EUR 280 |
Influenza virus B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cells Cell Lysate (WB positive control) |
MBS8115775-5x03mg |
MyBiosource |
5x0.3mg |
EUR 1205 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin Antibody Pair Set |
ABPR-ZB267 |
Creative Diagnostics |
5 plates, 15 plates |
Ask for price |
Description: Quantitative determination of Influenza Hemagglutinin |
H1N1 Influenza A- Virus Brisbane 59/2007 Recombinant |
rAP-5423 |
Angio Proteomie |
Inquiry |
Ask for price |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
MBS8118343-15Plates |
MyBiosource |
15Plates |
EUR 800 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
MBS8118343-5Plates |
MyBiosource |
5Plates |
EUR 450 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
MBS8118343-5x15Plates |
MyBiosource |
5x15Plates |
EUR 3695 |
Influenza A H3N2 (A/Brisbane/10/2007) HA Protein (HA1 Subunit), His Tag |
E40VAG022 |
EnoGene |
20ug |
EUR 495 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (AP) |
MBS6481610-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (AP) |
MBS6481610-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (PE) |
MBS6481620-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (PE) |
MBS6481620-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A H1N1 (A/Brisbane/59/2007) HA protein, His Tag |
E40VAG011 |
EnoGene |
20ug |
EUR 495 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (APC) |
MBS6481611-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (APC) |
MBS6481611-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (HRP) |
MBS6481614-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (HRP) |
MBS6481614-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (FITC) |
MBS6481613-01mL |
MyBiosource |
0.1mL |
EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (FITC) |
MBS6481613-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4765 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
MBS8104742-002mL |
MyBiosource |
0.02mL |
EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
MBS8104742-01mL |
MyBiosource |
0.1mL |
EUR 365 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
MBS8104742-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1490 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104746-002mL |
MyBiosource |
0.02mL |
EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
MBS8104746-01mL |
MyBiosource |
0.1mL |
EUR 385 |
-
Research design: The goal was to match a business IgG and IgA ELISA (Euroimmun) with three lateral stream immunoassays (LFI): Hangzhou Alltest Biotech, Wuhan UNscience Biotechnology and Guangzhou Wondfo Biotech. Specificity was calculated with 62 out there serum samples from 2018/19. The examine included 152 sera from sufferers of which 109 have been RT-PCR constructive. Sensitivities for ELISA anti SARS-CoV-2 IgG and IgA have been 81.5 % and 93.1 % and specificities 100 % and 80.6 %, respectively. LFI confirmed variable performances, general outcomes being higher for Guangzhou Wondfo Biotech.
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit
-
Conclusions: Industrial serological assessments are helpful for detection of antibodies in sufferers with COVID-19. ELISA introduced higher outcomes than LFI. The outcomes allowed to include essentially the most delicate LFI to the day by day workflow, combining with ELISA. Cautious validation is inspired earlier than scientific laboratories begin utilizing these assessments.